Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy

Blood (2023) 142 (Supplement 1): 850.

https://doi.org/10.1182/blood-2023-190851

Published: 2023

Journal Articles

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Blood (2023) 142 (Supplement 1): 2819.

https://doi.org/10.1182/blood-2023-178059

Published: 2023

Journal Articles

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Blood (2023) 142 (Supplement 1): 2986.

https://doi.org/10.1182/blood-2023-174325

Published: 2023

Journal Articles

Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma

Grace M. Pindzola, Raud Razzaghi, Rachel N. Tavory, Hang T. Nguyen, Vivian M. Morris, Moyi Li, Shreya Agarwal, Bonnie Huang, Takaharu Okada, Hans C. Reinhardt, Gero Knittel, Hamid Kashkar, Ryan M. Young, Stefania Pittaluga, Jagan R. Muppidi

Blood (2022) 140 (10): 1119–1131.

https://doi.org/10.1182/blood.2022015926

Published: 2022

Includes: Supplemental data

Journal Articles

Modeling and targeting of erythroleukemia by hematopoietic genome editing

Blood (2021) 137 (12): 1628–1640.

https://doi.org/10.1182/blood.2020009103

Published: 2021

Includes: Supplemental data

Journal Articles

Multiplex CRISPR/Cas9-Based Genome Editing of Mouse Hematopoietic Stem Cells Recapitulates Acute Erythroid Leukemia and Identifies Therapeutic Targets

Ilaria Iacobucci, PhD, Elena Varotto, MD, Chunxu Qu, PhD, Laura Janke, DVM, PhD, Aman Seth, PhD, Anang Shelat, PhD, Burgess Freeman, PhD, James Kennedy, Adam S Sperling, MD PhD, R. Coleman Lindsley, MD PhD, Kirsten Dickerson, BS, Debbie Payne-Turner, Sarah M Morris, Nina Ghosn, Benjamin L. Ebert, MDPhD, Charles G. Mullighan, MBBS, MD

Blood (2018) 132 (Supplement 1): 5.

https://doi.org/10.1182/blood-2018-99-118817

Published: 2018

Journal Articles

Invariant natural killer T cell–natural killer cell interactions dictate transplantation outcome after α-galactosylceramide administration

Rachel D. Kuns, Edward S. Morris, Kelli P. A. MacDonald, Kate A. Markey, Helen M. Morris, Neil C. Raffelt, Tatjana Banovic, Alistair L. J. Don, Vanessa Rowe, Angela C. Burman, Andrew D. Clouston, Camile Farah, Gurdyal S. Besra, Petr A. Illarionov, Mark J. Smyth, Steven A. Porcelli, Geoffrey R. Hill

Blood (2009) 113 (23): 5999–6010.

https://doi.org/10.1182/blood-2008-10-183335

Published: 2009

Journal Articles

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control

April L. Ferre, Peter W. Hunt, J. William Critchfield, Delandy H. Young, Megan M. Morris, Juan C. Garcia, Richard B. Pollard, Hal F. Yee, Jr, Jeffrey N. Martin, Steven G. Deeks, Barbara L. Shacklett

Blood (2009) 113 (17): 3978–3989.

https://doi.org/10.1182/blood-2008-10-182709

Published: 2009

Includes: Supplemental data

Journal Articles

Induction of Invariant NKT Cell-Dependent Alloreactivity by Administration of G-CSF after Bone Marrow Transplantation

Edward S Morris, DM, Kelli P A MacDonald, PhD, Rachel D Kuns, BSc, Helen M Morris, BSc, Tatjana Banovic, MD, Alistair LJ Don, BSc, Vanessa Rowe, MSc, Angela C Burman, PhD, Kate A Markey, BSc, Dale I Godfrey, PhD, Mark J Smyth, PhD, Geoff Hill, MD

Blood (2008) 112 (11): 3499.

https://doi.org/10.1182/blood.V112.11.3499.3499

Published: 2008

Journal Articles

Eculizumab Reduces Pulmonary Hypertension through Inhibition of Hemolysis-Associated Nitric Oxide Consumption in Patients with Paroxysmal Nocturnal Hemoglobinuria

Anita Hill, MD, Russell P. Rother, PhD, Xunde Wang, MD, Robert J Sapsford, MD, Paul O Collinson, MD, David C Gaze, PhD, Sidney M Morris, Jr., PhD, Andrew Scally, Kerry Quinn-Senger, PhD, Stephen J Richards, PhD, Monica Bessler, MD, PhD, Richard Kelly, MD, Peter Hillmen, MBChB, PhD, Mark Gladwin, MD

Blood (2008) 112 (11): 486.

https://doi.org/10.1182/blood.V112.11.486.486

Published: 2008

Journal Articles

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease

Gregory J. Kato, Vicki McGowan, Roberto F. Machado, Jane A. Little, James Taylor, VI, Claudia R. Morris, James S. Nichols, Xunde Wang, Mirjana Poljakovic, Sidney M. Morris, Jr, Mark T. Gladwin

Blood (2006) 107 (6): 2279–2285.

https://doi.org/10.1182/blood-2005-06-2373

Published: 2006

Includes: Supplemental data

Journal Articles

Lactate Dehydrogenase as a Biomarker of Hemolysis-Associated Nitric Oxide Resistance, Priapism, Leg Ulceration, Pulmonary Hypertension and Death in Patients with Sickle Cell Disease.

Gregory J. Kato, MD, Vicki McGowan, BS, Roberto F. Machado, MD, Jane A. Little, MD, James Taylor, VI, MD, Claudia R. Morris, MD, James S. Nichols, RN, Xunde Wang, PhD, Mirjana Poljakovic, PhD, Sidney M. Morris, Jr., PhD, Mark T. Gladwin, MD

Blood (2005) 106 (11): 3188.

https://doi.org/10.1182/blood.V106.11.3188.3188

Published: 2005

Journal Articles

Phase II Study of Decitabine in Combination with Imatinib Mesylate in Patients with Accelerated (AP) or Blastic Phase (BP) of Chronic Myeloid Leukemia (CML).

Yasuhiro Oki, MD, Hagop M. Kantarjian, MD, Susan O’Brien, MD, Srdan Verstovsek, M.D, Ph.D, Vazaganush Gharibyan, Jorge Cortes, MD, Gail M. Morris, Guillermo Garcia-Manero, MD, Jean-Pierre Issa, MD

Blood (2005) 106 (11): 1099.

https://doi.org/10.1182/blood.V106.11.1099.1099

Published: 2005

Journal Articles

The Arginine-to-Ornithine Ratio: Biomarker of Arginase Activity and Predictor of Mortality in Sickle Cell Disease.

Claudia R. Morris, MD, Gregory Kato, MD, Mirjana Poljakovic, PhD, William C. Blackwelder, Stan Hazen, MD, PhD, Elliott P. Vichinsky, MD, Sidney M. Morris, Jr., PhD, Mark T. Gladwin, MD

Blood (2004) 104 (11): 237.

https://doi.org/10.1182/blood.V104.11.237.237

Published: 2004

Journal Articles

A novel silent posttranslational mechanism converts methionine to aspartate in hemoglobin Bristol (beta 67[E11] Val-Met->Asp)

DC Rees, J Rochette, C Schofield, B Green, M Morris, NE Parker, H Sasaki, A Tanaka, Y Ohba, JB Clegg

Blood (1996) 88 (1): 341–348.

https://doi.org/10.1182/blood.V88.1.341.341

Published: 1996

NARROW

Exceptional Response to BTK Inhibitors in Aggressive Lymphomas Linked to Chronic Selective Autophagy

Molecular Determinants of Sensitivity to Polatuzumab-Vedotin in Diffuse Large B-Cell Lymphoma

Molecular Mechanism of Action of Glucocorticoids in Lymphoma Therapy

Aberrant expansion of spontaneous splenic germinal centers induced by hallmark genetic lesions of aggressive lymphoma

Modeling and targeting of erythroleukemia by hematopoietic genome editing

Multiplex CRISPR/Cas9-Based Genome Editing of Mouse Hematopoietic Stem Cells Recapitulates Acute Erythroid Leukemia and Identifies Therapeutic Targets

Invariant natural killer T cell–natural killer cell interactions dictate transplantation outcome after α-galactosylceramide administration

Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control

Induction of Invariant NKT Cell-Dependent Alloreactivity by Administration of G-CSF after Bone Marrow Transplantation

Eculizumab Reduces Pulmonary Hypertension through Inhibition of Hemolysis-Associated Nitric Oxide Consumption in Patients with Paroxysmal Nocturnal Hemoglobinuria

Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease

Lactate Dehydrogenase as a Biomarker of Hemolysis-Associated Nitric Oxide Resistance, Priapism, Leg Ulceration, Pulmonary Hypertension and Death in Patients with Sickle Cell Disease.

Phase II Study of Decitabine in Combination with Imatinib Mesylate in Patients with Accelerated (AP) or Blastic Phase (BP) of Chronic Myeloid Leukemia (CML).

The Arginine-to-Ornithine Ratio: Biomarker of Arginase Activity and Predictor of Mortality in Sickle Cell Disease.

A novel silent posttranslational mechanism converts methionine to aspartate in hemoglobin Bristol (beta 67[E11] Val-Met->Asp)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only